Skip to content

Private draft · Not published · For internal review

KeyMaker Studio · Proposed operating model

Build healthcare companies around problems buyers have validated.

KeyMaker Studio is designed to find recurring healthcare problems, test them with buyers, and build a company only when the evidence supports the next step.

Stages
Four decision gates
Evidence
Buyer-confirmed problems
Status
Concept draft for review

Material study 01

Light / edge

Abstract concept imagery. Not a client, partner, or portfolio company.

The four stages

A concept advances only when the evidence does.

Each stage answers a different question, and each ends at a decision. Durations are proposed planning ranges, not commitments.

  1. 01

    2–4 weeks

    Thesis

    Define the problem, buyer, urgency, and reason to act.

  2. 02

    6–8 weeks

    Validate

    Interview buyers, map the workflow, and seek a committed design partner.

  3. 03

    10–12 weeks

    Build

    Develop and test an initial product with a shared team, using agreed requirements and acceptance criteria.

  4. 04

    By decision

    Spin Out

    Recruit a dedicated CEO, establish the company structure, and define its own team and funding path.

Decision gate

Each stage has a decision gate. A concept can advance, change direction, or stop.

Stage detail

Positioning

KeyMaker Studio develops healthcare companies around problems buyers have validated.

A recurring problem is the starting asset. A committed buyer is the evidence. A company is the outcome only when both hold.

Stopping is a decision

Stopping a concept early can be a sound operating decision.

When buyer demand, access to the workflow, the economics, or a workable regulatory path are absent, continuing is the riskier choice. A concept that cannot reach its users or carry its obligations does not become viable with more time.

Stopping preserves resources for concepts with stronger evidence. It is treated as a deliberate management decision, recorded like any other gate outcome, rather than as a failure of the team that raised the problem.

Who this draft is for

Four groups, one shared expectation: evidence before commitment.

Potential founding CEOs and operators
Leaders who want to build a company around a validated healthcare problem, with an accountable role from the first day of a spinout.
Healthcare organizations
Providers, health plans, and other buyers considering a written design partnership around a problem they already experience.
Collaborators
People who can help test a problem with buyers, define requirements, or build and review an initial product.
Internal leadership
Reviewers of the proposed operating model, including the gates, stop criteria, and separation of client work from Studio work.

Discipline in what we show

What this draft does not claim.

A studio that asks buyers for evidence should hold its own site to the same standard. Approved material will be added only after review.

  • 01

    KeyMaker Studio is not an active fund, and nothing here is an offer of investment or a solicitation.

  • 02

    No launched company portfolio, completed spinout, or operating company is presented.

  • 03

    No client names, partner logos, testimonials, or case studies appear without written approval.

  • 04

    No product efficacy, clinical impact, cost savings, regulatory approval, or reimbursement is claimed.

  • 05

    No traction metrics, market-size estimates, or buyer commitments are published in this draft.